E. Bessa
About
In The Last Decade
E. Bessa
11 papers receiving 369 citations
Peers
Comparison fields: 5 of 49
- Oncology 237
- Pulmonary and Respiratory Medicine 173
- Otorhinolaryngology 155
- Molecular Biology 88
- Surgery 54
Countries citing papers authored by E. Bessa
This map shows the geographic impact of E. Bessa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Bessa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Bessa more than expected).
Fields of papers citing papers by E. Bessa
This network shows the impact of papers produced by E. Bessa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Bessa. The network helps show where E. Bessa may publish in the future.
Co-authorship network of co-authors of E. Bessa
This figure shows the co-authorship network connecting the top 25 collaborators of E. Bessa. A scholar is included among the top collaborators of E. Bessa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Bessa. E. Bessa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 139 | |
| 2 | 26 | |
| 3 | 3 | |
| 4 | 20 | |
| 5 | 87 | |
| 6 | 3 | |
| 7 | 3 | |
| 8 | [Phase II study of docetaxel in inoperable advanced non small cell lung cancer]. | 9 |
| 9 | [Efficacy of docetaxel in non-small cell lung cancer patients previously treated with platinum-containing chemotherapy. French Group of Pneumo-Cancerology]. | 8 |
| 10 | 24 | |
| 11 | 54 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.